Stay updated on BIO89-100 Multiple Dose in NASH Clinical Trial

Sign up to get notified when there's something new on the BIO89-100 Multiple Dose in NASH Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BIO89-100 Multiple Dose in NASH Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The completed pegozafermin study record is displayed instead of the error page, with details on its design, outcomes, locations, eligibility criteria, and study documents.
    Difference
    73%
    Check dated 2026-11-10T16:34:38.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T16:50:34.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    A general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The clinical trial record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T18:59:52.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T19:50:08.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, shown with a basic HTML structure and site footer, indicating restricted access to the study information.
    Difference
    20%
    Check dated 2026-09-22T22:22:03.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, indicating a software version upgrade. It represents a backend update reflected in the page's revision label.
    Difference
    0.0%
    Check dated 2026-09-15T21:42:52.000Z thumbnail image

Stay in the know with updates to BIO89-100 Multiple Dose in NASH Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BIO89-100 Multiple Dose in NASH Clinical Trial page.